Aptamer-Conjugated Tin Oxide Nanoparticles for Noninvasive Detection of Cancer Authors: Haneul Shin, Yul Min Lee, Seungho Lee, Dain Kim, Nohyun Lee, Kyun Heo, Sanggyu Yim Published: 2026 ABSTRACT To fundamentally address the limited tissue penetration of conventional fluorescence-based imaging, X-ray attenuation–based imaging approaches have been proposed. In this study, mesoporous tin oxide (SnO2) nanoparticles (NPs) with a diameter of approximately 70 nm were synthesized and functionalized with PAp7T8 and HER2apt28 aptamers, which target pancreatic and breast cancer cells, respectively. The synthesized SnO2 NPs exhibit greater X-ray attenuation than any of the tested metal oxide NPs in the tens of keV energy range corresponding to plain X-ray imaging. The surface-conjugated aptamers enable selective binding of the NPs to cancer cells, leading to efficient cellular uptake and internalization. In a model X-ray imaging experiment, as little as 5 mg of the SnO2 NPs placed beneath 3 cm-thick biological tissues is distinctly identified with high contrast. Overall, the excellent X-ray attenuation capabilities and target specificity of these aptamer-conjugated SnO2 NPs demonstrate their significant potential as a nanoplatform for the noninvasive imaging and diagnosis of deep-seated cancers. Introduction Although optical imaging of cancer using fluorescent nanomaterials has been extensively investigated, its application to real-time noninvasive diagnosis of deep-seated cancers remains limited because incident and emitted signals exhibit shallow tissue penetration. − Alternative strategies employing near-infrared fluorescence, which penetrates deeper than visible light, have also been explored; however, visualization of probe materials located more than 2 cm beneath the skin remains nearly impossible. , To overcome this limitation fundamentally, we recently proposed an imaging approach based on X-ray attenuation, which enables almost unlimited tissue penetration depth. , Effective X-ray attenuation was achieved using silicon dioxide (SiO2) nanoparticles (NPs) incorporating cesium lead bromide quantum dot scintillators. However, potential lead toxicity from the quantum dots and relatively low X-ray absorption of SiO2 remain significant obstacles to the practical application of this approach as a diagnostic tool. In this study, tin oxide (SnO2) NPs were used as probe materials because they exhibit remarkable X-ray attenuation characteristics at tens of keV, which is the energy range used in plain X-ray imaging. SnO2 NPs have attracted growing attention in various optoelectronic and physicochemical studies owing to their high stability, excellent photosensitivity, abundant availability, low cost, and nontoxicity. − Especially, their high electron mobility and appropriate energy band positions enable effective electron separation and transfer, supporting applications in energy conversion and storage devices, gas sensors, and photocatalysts. − Biomedical applications based on their antibacterial, antioxidant, and cytotoxic properties have also been reported. − Typically, the surface of metal oxide NPs used in biomedical applications is modified to enable selective adhesion to target cells. Various targeting moieties, including antibodies, aptamers, peptides, and receptor ligands, have been introduced. − Aptamers are short single-stranded DNA or RNA oligonucleotides selected in vitro to bind specific target molecules with high affinity and specificity, functioning as molecular recognition elements comparable to those of antibodies. − Recent advances in aptamer technology, particularly through integration with nanomaterials, have further demonstrated their expanding roles in targeted delivery, diagnostics, and precision cancer therapy. − Unlike protein-based antibodies, aptamers can be chemically synthesized with high batch-to-batch reproducibility and are generally more stable under a wide range of temperatures and pH conditions. , This stability enables aptamers to retain binding activity during NP functionalization and under storage conditions that may compromise antibody structure and function. , Furthermore, their relatively small molecular size can improve target accessibility and reduce steric hindrance, while terminal functional groups allow controlled conjugation to NP surfaces through diverse chemistries. , Collectively, these properties support the use of aptamers as targeting ligands in NP-based systems for selective cancer detection and therapy. − Here, we evaluated an aptamer-based targeting strategy using HER2apt28 and PAp7T8 as representative cancer-targeting aptamers. HER2apt28 is a HER2-specific DNA aptamer that selectively binds to HER2-overexpressing breast cancer cells and has been previously validated for breast cancer targeting. PAp7T8 is a pancreatic ductal adenocarcinoma (PDAC)-targeting aptamer that selectively binds to pancreatic cancer cells and has been shown to preferentially accumulate in orthotopic pancreatic tumors. In this study, SnO2 nanospheres with a diameter of approximately 70 nm were successfully synthesized, and their surfaces were conjugated with HER2 and PAp7T aptamers targeting breast and pancreatic cancer cells, respectively. The resulting aptamer-conjugated SnO2 NPs exhibited excellent X-ray attenuation and cancer-targeting capabilities, suggesting their potential as novel noninvasive diagnostic nanomaterials for deep-seated cancers. Experimental Section Materials Potassium stannate trihydrate (K2SnO3·3H2O, 99.9%), urea (99.5%), 3-aminopropyl triethoxysilane (APTES, ≥98%), and 4-(N-maleimidomethyl)­cyclohexane-1-carboxylic acid 3-sulfo-N-hydroxysuccinimide ester sodium salt (sulfo-SMCC) were purchased from Sigma-Aldrich and used as received. Ethylene glycol (99%) and anhydrous ethanol (99.8%) were purchased from DAEJUNG and used without further purification. All aptamers used in this study, anti-HER2 aptamer (HER2apt28), HER2 control aptamer (HER2aptctl), antipancreatic cancer cell aptamer (PAp7T8), and its corresponding control aptamer (PAp7T8R), were synthesized by Bioneer Corporation (South Korea), with Cy5 conjugated to a C6 linker at the 5′-end and an S–S linker attached via a C3 linker at the 3′-end. Synthesis of SnO2 NPs First, 1.67 g of K2SnO3·3H2O and 1.67 g of urea, corresponding to concentrations of 0.08 and 0.40 M, respectively, were dissolved in 70 mL of a mixed solvent of deionized water and ethylene glycol (1:1 v/v) under vigorous stirring. The reaction mixture was then transferred into a 90 mL Teflon-lined stainless-steel autoclave and heated at 200 °C for 12 h. After cooling down to room temperature (RT), the synthesized SnO2 NPs were collected by centrifugation and washed three times with ethanol. The obtained white powder was dried overnight at 70 °C and postannealed at 300 °C for 2 h. Surface Modification and Aptamer Conjugation The synthesized SnO2 NPs were dispersed in anhydrous ethanol at a concentration of 5 mg/mL. An excess amount of APTES was added to the dispersion, followed by stirring at 65 °C for 2 h. The amine-functionalized SnO2 NPs were then collected by centrifugation, washed three times with acetone, and dried overnight at 70 °C. For breast cancer targeting, the anti-HER2 aptamer HER2apt28, which specifically recognizes HER2-positive cancer cells, and its complementary-sequence negative control aptamer HER2aptctl were used. Likewise, for pancreatic cancer targeting, the antipancreatic cancer cell aptamer PAp7T8, which specifically recognizes PDAC cells, and its reverse-sequence negative control aptamer PAp7T8R were used to assess target-specific binding. Thiol–maleimide coupling chemistry was then used to conjugate aptamers to the amine-functionalized SnO2 NP surface. The aptamers were reduced in 0.1 M triethylammonium acetate containing 1 mM tris­(2-carboxyethyl)­phosphine (TCEP) at 70 °C for 3 min, followed by incubation at RT for 1 h. Excess TCEP was removed by buffer exchange into phosphate-buffered saline (PBS) supplemented with 2 mM ethylenediaminetetraacetic acid using centrifugal filters (Amicon Ultra, 3 kDa molecular weight cutoff, Millipore, USA). The amine-functionalized SnO2 NPs were activated with 10 μM sulfo-SMCC in PBS for 30 min at RT to introduce maleimide groups, after which unreacted cross-linkers were removed by centrifugation. The maleimide-activated SnO2 NPs were then incubated with the reduced thiolated aptamers at RT for 18 h to allow covalent conjugation. Unbound aptamers were removed by centrifugation, and the resulting aptamer-conjugated NPs were washed with PBS. The successful conjugation of aptamers onto SnO2 NPs was verified by confocal microscopy. For fluorescence visualization, Cy5-labeled aptamer–conjugated SnO2 NPs were deposited onto a glass slide and covered with a coverslip. Bare SnO2 NPs and Cy5-labeled aptamer–conjugated SnO2 NPs were then analyzed using a confocal microscope (LSM 780, Carl Zeiss, Germany) equipped with a 63× objective lens. All images were acquired under identical imaging conditions and processed using ZEN software (Carl Zeiss). Cell Lines Human normal pancreatic epithelial cells (hTERT-HPNE) and pancreatic ductal adenocarcinoma cells (CFPAC-1) were purchased from the American Type Culture Collection (Manassas, USA). hTERT-HPNE cells were cultured in a mixture of glucose-free Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco, USA) and M3 Base Medium (Incell Corporation, USA) at a ratio of 75:25 (v/v), supplemented with 5% heat-inactivated fetal bovine serum (FBS, Gibco) and 750 ng/mL puromycin. CFPAC-1 cells were maintained in Iscove’s Modified Dulbecco’s Medium (Gibco) supplemented with 10% heat-inactivated FBS and an antibiotic–antimycotic solution. Human breast adenocarcinoma cell lines (SK-BR-3 and MDA-MB-231) were obtained from the Korea Biotechnology Commercialization Center (South Korea). SK-BR-3 cells were cultured in Roswell Park Memorial Institute medium (Gibco), whereas MDA-MB-231 cells were maintained in DMEM. Both media were supplemented with 10% heat-inactivated FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco). All cell lines were cultured at 37 °C in a humidified incubator with 5% CO2. Western Blot Analysis Breast cancer cells (2.5 × 105 cells per well) were lysed in RIPA buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, Thermo Fisher Scientific, USA). Protein concentrations were determined using the BCA Protein Assay Kit (Thermo Fisher Scientific). Equal amounts of protein (10 μg) were separated by 12% SDS–PAGE and transferred onto nitrocellulose membranes (Amersham, UK). The membranes were blocked with 5% bovine serum albumin in Tris-buffered saline containing 0.1% Tween 20 (TBST) at RT for 1 h, then incubated overnight at 4 °C with primary antibodies against HER2 (1:1000, #2165, Cell Signaling Technology, USA) and β-actin (1:1000, #sc-47778, Santa Cruz Biotechnology, Germany). After washing six times with TBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies at RT for 1 h. Protein bands were visualized using enhanced chemiluminescence (ECL, Thermo Fisher Scientific), and images were acquired using an Amersham ImageQuant 800 imaging system (Cytiva, USA). Flow Cytometry Flow cytometry was performed to assess the binding capacity of the Cy5-labeled aptamer–conjugated NPs. Briefly, 250 nM Cy5-labeled aptamer–NPs were incubated with MDA-MB-231, SK-BR-3, hTERT-HPNE, or CFPAC-1 cells (5 × 105 cells) in binding buffer (Dulbecco’s PBS supplemented with 5 mM MgCl2, 0.1 mg/mL tRNA, and 1 mg/mL bovine serum albumin) at 4 °C for 30 min. After incubation, the cells were washed three times with binding buffer containing 0.1% NaN3 to remove unbound aptamer–NP conjugates. The cell pellets were then resuspended in binding buffer, and fluorescence signals corresponding to bound Cy5-labeled aptamer–conjugated NPs were analyzed using a SONY SH800 cell sorter (Sony Biotechnology Inc., USA). For each sample, 10,000 events were collected, and the data were analyzed using FlowJo software (v10.0.7, BD Biosciences). Cellular Uptake Analysis MDA-MB-231, SK-BR-3, hTERT-HPNE, or CFPAC-1 cells (5 × 103 cells) were seeded onto poly-l-lysine–coated eight-well chamber slides (Nunc Lab-Tek, USA). After 24 h of incubation, the cells were treated with 125 nM Cy5-labeled aptamer–conjugated NPs in complete culture medium at 37 °C for 20 min, 1 h, or 4 h. After incubation, the cells were washed with PBS, fixed with 4% paraformaldehyde, and counterstained with Hoechst 33342. The samples were subsequently imaged by confocal microscopy (Leica Microsystems, Germany). The obtained images were analyzed using Leica Application Suite X (LAS X) software. Cell Viability Analysis CFPAC-1, SK-BR-3, and hTERT-HPNE cells (5 × 103 cells) or MDA-MB-231 cells (1 × 104 cells) were seeded in 96-well plates and cultured for 24 h. The cells were then treated with various concentrations of NPs for 48 h. Cell viability was determined using the CellTiter-Glo Luminescent Cell Viability Assay (Promega, USA) according to the manufacturer’s protocol. Luminescence was measured using a microplate reader (BioTek, USA), and cell viability was normalized to that of untreated control cells. Characterization The morphology of the synthesized NPs was characterized using field-emission scanning electron microscopy (FE-SEM, JSM-7610F, JEOL Ltd.). The size of the NPs was examined using ImageJ software (ver. 1.52) and a particle size analyzer (ELSZ-2000ZS, Otsuka). The polydispersity index (PDI) and zeta potential of the NPs were determined based on dynamic light scattering (DLS) measurements. The crystalline properties of the NPs were investigated using powder X-ray diffraction (XRD, Rigaku Ultima IV). The specific surface area and porosity were estimated using a Brunauer–Emmett–Teller (BET) surface area analyzer (ASAP 2460, Micromeritics). The surface modification of the NPs was confirmed by a Fourier transform infrared (FTIR) spectrometer (Nicolet iS50, Thermo Fisher) and X-ray photoelectron spectroscopy (XPS, ESCALAB250, Thermo Scientific). Cy5 fluorescence of PBS, bare SnO2 NPs, and Cy5-labeled aptamer–conjugated SnO2 NPs was quantitatively analyzed using a fluorescence microplate reader (Synergy H1, BioTek) at excitation and emission wavelengths of 630 and 670 nm, respectively. X-ray attenuation measurements were performed using a home-built X-ray system equipped with a thallium-doped cesium iodide (CsI:Tl) flat-panel detector and an integrating sphere to collect spectral data. To compare the X-ray attenuation of lab-synthesized SnO2 and SiO2 NPs, commercially available Fe2O3 (Sigma-Aldrich, 50–100 nm particle size, 97%), PbO (Sigma-Aldrich, ≥99.9%), silver (SkySpring, 50–60 nm size, ≥99.9%), and copper (Sigma-Aldrich, 40–60 nm size, ≥99.5%) NPs were purchased. Clinical animal X-ray imaging equipment (CRUX 102i, iRAY) was also used in model experiments to evaluate the X-ray attenuation of NPs placed deep in tissues. Results and Discussion Synthesis of SnO2 NPs SnO2 NPs with an average diameter of approximately 70 nm were successfully synthesized using a simple hydrothermal method with 0.08 M K2SnO3·3H2O as a precursor and 0.40 M urea as a reducing agent (Figure a). The average diameter was obtained by examining approximately two hundred NPs using ImageJ software (Figure S1a). A significantly small PDI value of 0.176 determined from DLS measurements indicates a narrow size distribution of the NPs (Figure S1b). The synthesized NPs remained well dispersed in water for at least 72 h, as shown in the inset of Figure a. The zeta potential (ζ) of the NPs was measured to be −118 mV, which also indicates high dispersibility of the NPs (Figure b) as |ζ| > 30 mV usually implies suspension stability. The highly negative ζ value indicates the presence of deprotonated functional groups on the NP surface, possibly due to basic byproducts such as K2CO3. After 72 h, the |ζ| value remained at a high value of −82 mV, indicating long-term dispersion stability of the NPs. The average size of the nanospheres increased with increasing precursor concentration (Figure c and Figure S2). This behavior can be attributed to larger mass transfer and consequently an increased NP growth rate at higher precursor concentrations. Therefore, to obtain relatively small particles with diameters below 100 nm, suitable for high mobility in the human body and efficient penetration into target tissues, the K2SnO3 precursor concentration should be maintained below 0.08 M. The XRD pattern of the synthesized SnO2 NPs agrees well with the tetragonal lattice of the rutile structure (JCPDS file No. 41–1445), although the peaks are slightly broadened due to the small particle size (Figure d). Based on the N2 adsorption–desorption isotherm plots (Figure e), the synthesized SnO2 NPs can be classified as typical mesoporous materials. , The specific surface area was estimated to be 54 m2/g, which is slightly larger than that of previously reported SnO2 NPs with similar sizes. − The inset of Figure e shows the Barrett–Joyner–Halenda (BJH) pore size distribution of the NPs, with an average pore diameter of approximately 19 nm. Postannealing at ≥200 °C was required to remove organic residues and suppress surface hydroxyl groups, as indicated by the reduction of O–H, C–H, and C–O vibrational bands (Figure f). (a) SEM image of synthesized SnO2 NPs and (inset) a photograph of NP-dispersed solution in water taken after 72 h. (b) Zeta potentials of SnO2 NPs measured immediately and 72 h after dispersion in water. (c) Plot of average NP diameters as a function of the K2SnO3 precursor concentration. (d) XRD pattern of the synthesized SnO2 NPs. (e) BET N2 adsorption–desorption isotherm plots and (inset) BJH pore-size distribution curve. (f) FTIR spectra of the pristine SnO2 NPs and postannealed at different temperatures. X-ray Attenuation Characteristics of SnO2 NPs Figure a shows plain X-ray images of NPs of four metal oxides (SnO2, Fe2O3, PbO, and SiO2) and two metals (Ag and Cu). Each 38 mg sample was placed in a plastic container with a diameter of 5 mm and irradiated with X-rays at a tube potential of 50 kVp. As shown in Figure a, the image of SnO2 appears significantly brighter than those of Fe2O3 and SiO2, probably because elements with higher atomic numbers exhibit greater X-ray attenuation. For a more quantitative evaluation, X-rays transmitted through the samples were converted to visible light using a CsI:Tl scintillator detector and their intensities were compared (Figure b–g). As summarized in Figure h, the average X-ray attenuation of SnO2 NPs was approximately 31%, which was higher than that of the metal oxide NPs, i.e., 28%, 15%, and 4% for PbO, Fe2O3, and SiO2 NPs, respectively. Despite the well-known X-ray shielding ability of Pb, the greater attenuation of SnO2 compared with PbO can be explained by the larger mass attenuation coefficient of SnO2 in the plain X-ray energy range of 40–60 kVp, as calculated from the National Institute of Standards and Technology database (Figure i). This behavior is attributed to the position of the K-shell absorption edge: the 1s electron binding energy of Sn (29.2 keV) lies below the plain X-ray energy range, whereas that of Pb is substantially higher (88.0 keV). (a) X-ray images of various metal oxide and metal NPs taken at a tube potential of 50 kVp. (b–g) X-ray intensities after passing through 38 mg of (b) SnO2, (c) Fe2O3, (d) PbO, (e) SiO2, (f) Ag and (g) Cu NPs. (h) Average X-ray attenuation of the NPs. (i) Mass attenuation coefficients of the NPs, calculated based on the NIST database. The inset shows a magnified image at a tube potential of approximately 50 kVp. Surface Modification of SnO2 NPs For aptamer conjugation, amine functional groups were first introduced to the surface of the synthesized SnO2 NPs using APTES. Successful modification was confirmed by the appearance of N–H stretching (at ∼3350 cm–1), C–H stretching (at 2800–3000 cm–1) and NH2 deformation (at 1658 and 1633 cm–1) vibrational bands originating from the surface-bound APTES in FTIR spectra (Figure a). − At the same time, the O–H band intensity decreased significantly since the modification occurred through silanization between APTES and O–H groups on the NP surface (Figure b). In XPS measurements, a marked increase in peak intensities in the binding energy regions corresponding to Si 2p and N 1s electrons, originating from the conjugated APTES molecules, was also observed (Figure c–e). (a) FTIR spectra, (b) schematic of amine functionalization, and (c–e) XPS spectra corresponding to (c) Sn 3d, (d) Si 2p, and (e) N 1s electrons of SnO2 NPs before and after treatment with APTES. Anti-HER2 (HER2apt28) and pancreatic cancer cell-specific (PAp7T8) aptamers, along with their corresponding control aptamers (HER2aptctl and PAp7T8R), were conjugated onto the SnO2 NP surface. Thiol–maleimide coupling chemistry was employed to enable covalent attachment of the thiolated aptamers to the NP surface (Figure S3). After the conjugation reaction, a distinct color change from white to blue was visually observed in the NP suspension (Figure a), consistent with the presence of Cy5-labeled aptamers on the NP surface. Aptamer conjugation was further examined using confocal microscopy. Bare SnO2 NPs exhibited negligible fluorescence, whereas aptamer-conjugated SnO2 NPs, including both target-specific and control aptamer conjugates, showed a distinct red fluorescence signal originating from the Cy5 fluorophore (Figure b). Additionally, the Cy5 fluorescence of the aptamer-conjugated SnO2 NPs was quantitatively analyzed using a fluorescence microplate reader. Negligible Cy5 fluorescence was detected in PBS and bare SnO2 NPs, whereas strong Cy5 fluorescence signals were observed for all Cy5-labeled aptamer–conjugated NPs (Figure S4). Collectively, these results provide consistent evidence for the successful formation of SnO2 NP–aptamer conjugates through the covalent immobilization of Cy5-labeled aptamers on the NP surface. The zeta potentials of the APTES-, PAp7T8-, and HER2apt28-treated SnO2 NPs were measured to be +70, −47, and −66 mV, respectively, indicating that the high dispersibility of the NPs is well maintained throughout the entire process (Figure S5). The sign change in ζ values is attributed to the basic NH2 groups of APTES and the negatively charged phosphate backbone of the aptamer, respectively, which also indicates successful amine functionalization and aptamer conjugation on the NP surface. , (a) Photographs of SnO2 NPs before and after conjugation with Cy5-labeled aptamers. A color change from white to blue was observed after aptamer conjugation. (b) Representative confocal microscopy images of bare and Cy5-labeled aptamer–conjugated SnO2 NPs. Scale bar = 10 μm. Cell-Specific Binding of Aptamer–NP Conjugates The binding specificity of Cy5-labeled aptamer–conjugated NPs toward different cell lines was evaluated by flow cytometry. Binding profiles were analyzed based on fluorescence intensity distributions corresponding to cell-associated Cy5 signals (Figure ). Flow cytometry histograms showing the binding of Cy5-labeled aptamer–NP conjugates (Cy5-apt–NPs) to (a) MDA-MB-231, (b) SK-BR-3, (c) hTERT-HPNE, and (d) CFPAC-1 cells. The resulting fluorescence intensity distributions were analyzed to evaluate the cell-specific binding of the NPs. For breast cancer cell lines, Cy5-labeled HER2-specific aptamer–NP conjugates (Cy5-HER2apt28–NPs) induced a rightward shift in fluorescence intensity in SK-BR-3 cells, which are HER2-positive breast cancer cell lines (Figure S6). In contrast, only minimal fluorescence shifts were observed in MDA-MB-231 cells, which are HER2-negative breast cancer cell lines, and in cells incubated with control aptamer–NP conjugates (Cy5-HER2aptctl–NPs) (Figure a,b). These results indicate that the enhanced binding of Cy5-HER2–NP conjugates depends on HER2 expression. Similarly, for pancreatic cancer cell lines, Cy5-labeled pancreatic cancer-specific aptamer–NP conjugates (Cy5-PAp7T8–NPs) exhibited increased fluorescence intensity in CFPAC-1 cells. In contrast, negligible fluorescence shifts were observed in the normal pancreatic epithelial cell line hTERT-HPNE and in cells treated with control aptamer–NP conjugates (Cy5-PAp7T8R–NPs), indicating limited nonspecific binding (Figure c,d). Collectively, these results demonstrate that aptamer–NP conjugates functionalized with target-specific aptamers selectively bind to cancer cells expressing the corresponding surface markers. Specifically, HER2-specific aptamer–NP conjugates preferentially associate with HER2-positive breast cancer cells compared with HER2-negative breast cancer cells, whereas pancreatic cancer-specific aptamer–NP conjugates exhibit enhanced binding to pancreatic cancer cells relative to normal pancreatic epithelial cells. Flow cytometric analysis thus provides functional validation that aptamer conjugation confers on SnO2 NPs target-specific cell-binding capability. Cellular Uptake and Internalization of Aptamer–NP Conjugates The cellular uptake and internalization of Cy5-labeled aptamer-conjugated SnO2 NPs were examined using confocal microscopy. Cy5-HER2apt28–NPs exhibited efficient cellular uptake in SK-BR-3 cells, whereas minimal intracellular fluorescence was observed in MDA-MB-231 cells, indicating HER2-dependent internalization (Figure a,b). Similarly, Cy5-PAp7T8–NPs showed pronounced intracellular accumulation in CFPAC-1 cells but negligible uptake in hTERT-HPNE cells (Figure c,d). Control aptamer–NP conjugates exhibited minimal intracellular fluorescence in all examined cell lines, indicating limited nonspecific uptake. In both SK-BR-3 and CFPAC-1 cells, the internalized aptamer–NP conjugates were predominantly localized in the perinuclear region. Confocal fluorescence microscopy images showing the cellular internalization of Cy5-labeled aptamer–NP conjugates in different cell lines: (a) MDA-MB-231, (b) SK-BR-3, (c) hTERT-HPNE, and (d) CFPAC-1. Cells were incubated with Cy5-labeled aptamer–NP conjugates at 125 nM and 37 °C for the indicated time points (20 min, 1 h, and 4 h), followed by nuclear staining with Hoechst 33342. Cy5 (red) and Hoechst (blue) fluorescence signals are shown. Scale bars = 20 μm. Collectively, these findings suggest that aptamer–target interactions contribute to the enhanced cellular uptake of the NPs. The selective uptake patterns observed in the target cell lines support the selective targeting capability of the aptamers. Validation for X-ray Imaging Applications To evaluate the applicability of the synthesized SnO2 NPs for X-ray imaging of deep-seated cancers, their cytotoxicity toward the tested cell lines and X-ray attenuation capability through tissue were evaluated. Figure a shows the relative cell viability (%) of cells 48 h after NP treatment. No significant cytotoxic effects were observed in the tested cell lines. According to ISO 10993–5, materials exhibiting cell viability above 70% are generally considered noncytotoxic, supporting the conclusion that the NPs exhibited low cytotoxicity under the tested conditions. To validate the X-ray attenuation ability of the synthesized SnO2 NPs beneath thick tissue, a model X-ray imaging experiment was conducted using several-centimeter-thick pork ribs (Figure b). Before imaging through tissue, various amounts of SnO2 NPs (5, 10, 20, and 40 mg) were examined without shielding at different tube potentials (40, 50, and 60 kVp) (Figure c). The X-ray beam intensity and source–image distance were fixed at 2 mAs and 100 cm, respectively. As the sample mass increased, greater X-ray attenuation was observed at each tube potential, although only minor differences in image brightness were detected among the different tube potentials. SnO2 NPs were also clearly identifiable beneath the pork ribs (Figure d,e). Figure d and e show images of the NPs located beneath muscle and bone at a tube potential of 60 kVp, respectively. Images obtained at other tube potentials are provided in the Supporting Information (Figure S7). Under muscle tissue, the contrast resolutions for 5, 10, 20, and 40 mg of SnO2 NPs were 0.063, 0.10, 0.14, and 0.16, respectively (Figure f). The contrast resolution is defined as (S ROI – S muscle)/(S ROI + S muscle), where S ROI and S muscle denote the average signal intensities of the region of interest (ROI) and the background muscle, respectively. (a) Cell viability after treatment with various NP concentrations for 48 h. Error bars represent the mean ± standard deviation (n = 3). (b) Photograph of approximately 3 cm-thick pork ribs used in the model experiments. (c) X-ray images of SnO2 NPs acquired at various tube potentials. The NP masses are 5, 10, 20, and 40 mg from bottom to top. (d, e) X-ray images of the NPs placed beneath muscle (d) and bone (e) of the pork ribs at a tube potential of 60 kVp. In each image, NP masses are 5, 10, 20, and 40 mg from left to right. (f) Calculated contrast resolutions and signal-to-noise (SNR) ratios. The NPs appeared brighter under bone than under muscle, indicating a combined X-ray attenuation effect from both the NPs and the bone. However, the contrast resolutions, defined as (S ROI – S bone)/(S ROI + S bone), were reduced to 0.033, 0.053, 0.10, and 0.15, because the surroundings of the ROI were brighter than those under muscle. Nevertheless, even 5 mg of SnO2 NPs placed under bone was readily distinguishable at the lowest contrast resolution of 0.033, which exceeds the minimum detectable contrast of the human eye (approximately 0.01). The signal-to-noise ratio (SNR), defined as the ratio of the average signal intensity to its standard deviation, was also calculated. The SNR values of the NPs under bone were higher in all cases than those under muscle, probably because bone provides a more uniform background than muscle in the image. These results indicate that ≥5 mg of the synthesized SnO2 NPs can be distinctly identified by plain X-ray imaging, even when located within deep tissues. Conclusion In this study, monodisperse SnO2 NPs with diameters ranging from 70 to 300 nm were successfully synthesized via a hydrothermal method using K2SnO3 precursors. The synthesized NPs exhibited mesoporous characteristics, and their size was strongly dependent on the precursor concentration. The X-ray attenuation efficiency of the synthesized SnO2 NPs in the plain X-ray range was significantly greater than that of Fe2O3 and SiO2 NPs, and even PbO NPs owing to their large mass attenuation coefficient and relatively low K-shell absorption edge of Sn. Cancer-targeting aptamers (HER2apt28 and PAp7T8) and their corresponding control aptamers (HER2aptctl and PAp7T8R) were successfully conjugated onto the SnO2 NP surface via amine functionalization followed by thiol–maleimide coupling. The aptamer functionalization enabled selective and target-dependent cellular internalization of the SnO2 NPs, with aptamer–NP conjugates predominantly localized in the perinuclear region. In model X-ray imaging experiments, as little as 5 mg of the NPs could be distinctly identified when placed beneath 3 cm-thick tissues, demonstrating the potential applicability of the synthesized SnO2 NPs for noninvasive imaging and diagnosis of deep-seated cancers. Supplementary Material